TE-8105

Asset

Investigational therapy for overweight or obesity

Stage: Phase 2
Modality: Peptide
Target: Lipid and ceramide metabolism; 1
Indication: 1
Trial: 1
Developer

Indications

1

Overweight and obesity
Phase 2, Not yet recruiting, NCT07857473, clinicaltrials.gov, 7 Oct 2026

In the full profile

Targets and what it contains1
Owner and partners1
Trials1
Evidence for its targets1
Competitors2
Aging relevance1
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source